BR112015010704A2 - partícula compósita, e, processo para preparar uma partícula compósita - Google Patents

partícula compósita, e, processo para preparar uma partícula compósita

Info

Publication number
BR112015010704A2
BR112015010704A2 BR112015010704A BR112015010704A BR112015010704A2 BR 112015010704 A2 BR112015010704 A2 BR 112015010704A2 BR 112015010704 A BR112015010704 A BR 112015010704A BR 112015010704 A BR112015010704 A BR 112015010704A BR 112015010704 A2 BR112015010704 A2 BR 112015010704A2
Authority
BR
Brazil
Prior art keywords
composite
ingestible
particle
nanoparticles
preparing
Prior art date
Application number
BR112015010704A
Other languages
English (en)
Other versions
BR112015010704B1 (pt
BR112015010704B8 (pt
Inventor
Knieke Catharina
To Daniel
A Bilgili Ecevit
A Azad Mohammed
dave Rajesh
Original Assignee
New Jersey Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Jersey Inst Technology filed Critical New Jersey Inst Technology
Publication of BR112015010704A2 publication Critical patent/BR112015010704A2/pt
Publication of BR112015010704B1 publication Critical patent/BR112015010704B1/pt
Publication of BR112015010704B8 publication Critical patent/BR112015010704B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • B05D1/18—Processes for applying liquids or other fluent materials performed by dipping
    • B05D1/22—Processes for applying liquids or other fluent materials performed by dipping using fluidised-bed technique

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)

Abstract

1 / 1 resumo “partãcula compã“sita, e, processo para preparar uma partãcula compã“sita” uma partã­cula compã³sita que inclui um nãºcleo com pelo menos um material carreador; uma camada de material fluidizante na superfã­cie do nãºcleo e uma camada externa que compreende nanopartã­culas de um material ingerã­vel distribuã­das em pelo menos um material formador de matriz. um processo de fabricar as partã­culas de compã³sito inclui as etapas de revestir as partã­culas de catalisador a seco com um material fluidizante; preparar uma suspensã£o de nanopartã­culas de um material ingerã­vel distribuã­da em um material formador de matriz e revestir as partã­culas de carreador no leito de fluido com a suspensã£o. o processo e os produtos fornecem partã­culas de compã³sito de dissoluã§ã£o rã¡pida que podem ser usados para a liberaã§ã£o de materiais ingerã­veis deficientemente solãºveis em ã¡gua em formas de dosagem adequadas. o processo da invenã§ã£o reduz ou evita a aglomeraã§ã£o de partã­culas durante a fabricaã§ã£o das partã­culas de compã³sito para permitir a liberaã§ã£o e a redispersã£o rã¡pida de nanopartã­culas do material ingerã­vel a partir de uma forma de dosagem.
BR112015010704A 2012-11-12 2013-11-08 Partícula compósita, e, processo para preparar uma partícula compósita BR112015010704B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261725301P 2012-11-12 2012-11-12
US61/725,301 2012-11-12
PCT/US2013/069128 WO2014074808A1 (en) 2012-11-12 2013-11-08 Pharmaceutical core-shell composite powder and processes for making the same

Publications (3)

Publication Number Publication Date
BR112015010704A2 true BR112015010704A2 (pt) 2017-07-11
BR112015010704B1 BR112015010704B1 (pt) 2022-05-31
BR112015010704B8 BR112015010704B8 (pt) 2022-06-14

Family

ID=50685172

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015010704A BR112015010704B8 (pt) 2012-11-12 2013-11-08 Partícula compósita, e, processo para preparar uma partícula compósita

Country Status (9)

Country Link
US (1) US9801820B2 (pt)
EP (1) EP2916824B1 (pt)
JP (1) JP6460562B2 (pt)
CN (1) CN104968332B (pt)
AR (1) AR093449A1 (pt)
BR (1) BR112015010704B8 (pt)
DK (1) DK2916824T3 (pt)
ES (1) ES2745759T3 (pt)
WO (1) WO2014074808A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10149826B2 (en) * 2015-01-20 2018-12-11 Hyalo Technologies, LLC Method of preparing microspheres
WO2017047650A1 (ja) * 2015-09-14 2017-03-23 大和製罐株式会社 粉末吸入剤、吸入器、及び粉末吸入剤の製造方法
WO2017050528A1 (en) * 2015-09-24 2017-03-30 Unilever N.V. Oral care composition
US9675609B2 (en) * 2015-11-11 2017-06-13 Cao Pharmaceuticals Inc. Nano- and micro-sized particles of 20-camptothecin or derivative thereof and pharmaceutical compositions containing same, and treatment of cancers therewith
JP6067154B1 (ja) * 2016-01-25 2017-01-25 株式会社樋口商会 コーティング粒子の製造方法
KR101809139B1 (ko) 2016-11-15 2017-12-15 주식회사 이코블록 무기물 코어에 유기물을 코팅하는 방법 및 그에 따른 용사코팅장치
WO2019038909A1 (ja) * 2017-08-25 2019-02-28 福田金属箔粉工業株式会社 積層造形用粉末の評価方法およびその積層造形用粉末
DE102017215328A1 (de) * 2017-09-01 2019-03-07 Henkel Ag & Co. Kgaa Treibmittelhaltige kosmetische Zusammensetzungen mit Pigment-haltigen Stärkepartikeln und anionischem Polymer
CN107649063B (zh) * 2017-11-02 2023-08-29 黑龙江省科学院自动化研究所 一种纳米材料超声共振乳化混配装置
EP3848037A4 (en) * 2018-09-03 2022-05-18 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. SOLID PHARMACEUTICAL COMPOSITION WITH 1,3,5-TRIAZINE DERIVATE OR A SALT THEREOF
CN109046187B (zh) * 2018-10-09 2023-05-23 天津西敦津洋环保科技有限公司 一种高充气率的气固流化床反应器、实现在流化床中高充气率的方法及其应用
JP7147523B2 (ja) * 2018-12-06 2022-10-05 三生医薬株式会社 造粒方法
US11549381B2 (en) * 2019-09-05 2023-01-10 Raytheon Technologies Corporation Coating fabrication method for producing engineered microstructure of silicate-resistant barrier coating
JP2023505142A (ja) * 2019-12-02 2023-02-08 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 活性医薬成分のナノ懸濁液の担体上の堆積
JP2023514924A (ja) * 2019-12-16 2023-04-12 ザ・グッドイヤー・タイヤ・アンド・ラバー・カンパニー シリカ被覆デンプン
KR20220144378A (ko) * 2020-02-19 2022-10-26 나노 파마솔루션즈, 인코포레이티드 치료제 나노입자 및 제조 방법
CN112522863B (zh) * 2020-11-26 2021-12-07 内蒙古工业大学 气流铺覆纤维装置
CN115386208A (zh) * 2022-08-11 2022-11-25 长兴电子（苏州）有限公司 可降解微珠及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US7276249B2 (en) 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
JP4547888B2 (ja) * 2003-10-10 2010-09-22 小野薬品工業株式会社 胃内浮遊性固形製剤
US7402175B2 (en) 2004-05-17 2008-07-22 Massachusetts Eye & Ear Infirmary Vision prosthesis orientation
RU2008148547A (ru) 2006-05-22 2010-06-27 Тева Фармасьютикл Индастриес Лтд. (Il) Фармацевтические композиции, включающие дулоксетина гидрохлорид с замедленным высвобождением
AU2007265452A1 (en) 2006-06-26 2008-01-03 Mutual Pharmaceutical Company, Inc. Active agent formulations, methods of making, and methods of use
EA200900270A1 (ru) * 2006-08-25 2009-08-28 Бёрингер Ингельхайм Интернациональ Гмбх Системы регулируемого высвобождения и способ их приготовления
BRPI0717721A2 (pt) * 2006-11-28 2013-10-29 Marinus Pharmaceuticals "partículas complexadas de drogas, composição farmacêutica, uso de uma composição farmacêutica, partículas complexadas de droga estabilizadas no tamanho, método para a preparação de partículas estabilizadas da droga, composição farmacêutica sólida, comprimido oral ingerível e composição líquida em nanopartículas estabilizadas no tamanho"
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them

Also Published As

Publication number Publication date
BR112015010704B1 (pt) 2022-05-31
AR093449A1 (es) 2015-06-10
CN104968332A (zh) 2015-10-07
WO2014074808A1 (en) 2014-05-15
DK2916824T3 (da) 2019-09-30
JP6460562B2 (ja) 2019-01-30
EP2916824B1 (en) 2019-06-19
US20150297521A1 (en) 2015-10-22
EP2916824A1 (en) 2015-09-16
JP2016503411A (ja) 2016-02-04
BR112015010704B8 (pt) 2022-06-14
CN104968332B (zh) 2020-10-20
ES2745759T3 (es) 2020-03-03
EP2916824A4 (en) 2016-08-17
US9801820B2 (en) 2017-10-31

Similar Documents

Publication Publication Date Title
BR112015010704A2 (pt) partícula compósita, e, processo para preparar uma partícula compósita
Caruso et al. Production of hollow microspheres from nanostructured composite particles
BR112017012363A2 (pt) microcápsulas revestidas
AR087664A1 (es) Mejoras relacionadas con composiciones para el tratamiento de superficies que comprenden agentes de beneficio direccionados
BR112015012469A2 (pt) pó formado de partículas, mais do que 95% em número de ditas partículas exibindo uma circularidade superior ou igual a 0,85, processo para a fabricação de um pó, processo de pulverização térmica e câmara de tratamento para semicondutores
BR112013003714A2 (pt) partícula de distribuição de agente de benefício, composição, composição de tratamento de lavagem e processo para produção de partícula de distribuição de agente de benefício
JP2013521533A5 (pt)
JP2014528983A5 (pt)
IN2014DN08762A (pt)
CO6270208A2 (es) Microesferas con estructura de medula/coraza
JP2013528829A5 (pt)
WO2010126606A3 (en) Functionalized matrixes for dispersion of nanostructures
CO6470853A2 (es) Material compuesto que comprende nanopartículas y peoducción de capas fotoactivas que contienen nanopartículas semiconductoras compuestas cuaternarias, pentanarias y de orden superior
BR112015002376A2 (pt) óxido de metal particulado, dispersão, método para fabricar partículas de óxido de metal, composição de protetor solar, e, uso de um óxido de metal particulado
WO2016199167A3 (en) Microcapsules modified with nanomaterial for controlled release of active agent and process for preparation thereof
WO2014022368A3 (en) Anti-reflective hard coat and anti-reflective article
MX2016002603A (es) Metodo para preparar una composicion comestible.
JP2012113301A5 (ja) トナー組成物
BR112012033806A2 (pt) composição na forma de uma partícula, método para sua preparação e uso da composição
BR112015008284A2 (pt) processo para preparar uma formulação farmacêutica particulada de gosto mascarado
BR112017023648A2 (pt) ?método para produzir um sistema de pintura em um substrato plástico, e, sistema de pintura de multirrevestimentos?.
HRP20190865T1 (hr) Postupak nanošenja fotokatalitičke disperzije i postupak proizvodnje panela
UA113190C2 (xx) Презерватив з покриттям
JP2013511602A5 (pt)
PH12016500855A1 (en) Pharmaceutical preparation and method of its production and use

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/11/2013, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2682 DE 31/05/2022 QUANTO AO ENDERECO.